-
Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step
Thursday, July 13, 2023 - 8:46am | 223Read More...Greg Gorgas, President & CEO of Artelo Biosciences (NASDAQ: ARTL), was recently a guest on Benzinga’s All-Access. Artelo is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways...
